Hemostatic Disorders Associated with Hepatobiliary Disease

Vet Clin North Am Small Anim Pract. 2017 May;47(3):601-615. doi: 10.1016/j.cvsm.2016.11.009. Epub 2016 Dec 27.

Abstract

The liver plays a crucial role in all aspects of coagulation because most factors that regulate procoagulation, anticoagulation, and fibrinolysis are produced, cleared, and/or activated in the liver. Establishing the coagulation status of an individual patient with hepatobiliary disease can therefore be challenging. Although, classically, patients with hepatobiliary disease were thought of as potentially hypocoagulable, hypercoagulability also occurs. The article summarizes the breadth of coagulation abnormalities that have been reported in dogs and cats with hepatobiliary disease and provides strategies to respond to bleeding and thrombotic risk.

Keywords: Coagulation; Hemorrhage; Hyperfibrinolysis; Liver; Portal vein thrombosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Biliary Tract Diseases / blood
  • Biliary Tract Diseases / diagnosis
  • Biliary Tract Diseases / therapy
  • Biliary Tract Diseases / veterinary*
  • Blood Coagulation Factors
  • Cat Diseases / blood*
  • Cat Diseases / diagnosis
  • Cat Diseases / therapy
  • Cats
  • Dog Diseases / blood*
  • Dog Diseases / diagnosis
  • Dog Diseases / therapy
  • Dogs
  • Hemostatic Disorders / blood
  • Hemostatic Disorders / diagnosis
  • Hemostatic Disorders / therapy
  • Hemostatic Disorders / veterinary*
  • Humans
  • Liver Diseases / blood
  • Liver Diseases / diagnosis
  • Liver Diseases / therapy
  • Liver Diseases / veterinary*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prothrombin Time / veterinary

Substances

  • Blood Coagulation Factors
  • Platelet Aggregation Inhibitors